Detalles de la búsqueda
1.
Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.
Value Health
; 26(1): 71-80, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973926
2.
Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review.
Clin Chem
; 67(1): 237-244, 2021 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33418577
3.
Exploring the Feasibility of Comprehensive Uncertainty Assessment in Health Economic Modeling: A Case Study.
Value Health
; 24(7): 983-994, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34243842
4.
Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation.
Value Health
; 24(8): 1126-1136, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34372978
5.
An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry.
Acta Oncol
; 59(9): 1123-1130, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32544366
6.
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry.
Qual Life Res
; 29(12): 3363-3374, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816222
7.
Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory?
Value Health
; 22(7): 799-807, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31277827
8.
Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments.
Qual Life Res
; 28(8): 2257-2279, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30929124
9.
Development of an isotoxic decision support system integrating genetic markers of toxicity for the implantation of a rectum spacer.
Acta Oncol
; 57(11): 1499-1505, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29952681
10.
Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP".
Int J Technol Assess Health Care
; 39(1): e70, 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822085
11.
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer.
Breast Cancer Res Treat
; 165(3): 485-498, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28689361
12.
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer.
Acta Oncol
; 61(5): 619-624, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139727
13.
How should we deal with patient heterogeneity in economic evaluation: a systematic review of national pharmacoeconomic guidelines.
Value Health
; 16(5): 855-62, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23947981
14.
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer.
Radiother Oncol
; 170: 95-101, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35259416
15.
State of the ART? Two New Tools for Risk Communication in Health Technology Assessments.
Pharmacoeconomics
; 39(10): 1185-1196, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34278550
16.
Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").
Orphanet J Rare Dis
; 16(1): 62, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33522936
17.
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials.
Radiother Oncol
; 164: 163-166, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34619235
18.
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 39(2): 171-180, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33145711
19.
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.
Pharmacoeconomics
; 39(12): 1429-1442, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34405371
20.
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer.
Radiother Oncol
; 158: 40-47, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587968